NeuroPace, Inc.
NPCE
$14.09
-$0.03-0.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.13% | 24.08% | 23.32% | 22.05% | 22.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.13% | 24.08% | 23.32% | 22.05% | 22.14% |
| Cost of Revenue | 9.34% | 10.11% | 15.75% | 18.03% | 20.36% |
| Gross Profit | 30.69% | 29.04% | 25.96% | 23.47% | 22.78% |
| SG&A Expenses | 15.00% | 13.47% | 8.66% | 1.52% | 4.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.52% | 13.63% | 12.26% | 8.49% | 9.70% |
| Operating Income | 24.61% | 21.00% | 19.81% | 27.00% | 20.25% |
| Income Before Tax | 20.91% | 14.61% | 13.23% | 21.27% | 17.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.91% | 14.61% | 13.23% | 21.27% | 17.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.91% | 14.61% | 13.23% | 21.27% | 17.64% |
| EBIT | 24.61% | 21.00% | 19.81% | 27.00% | 20.25% |
| EBITDA | 24.99% | 21.22% | 20.08% | 27.33% | 20.51% |
| EPS Basic | 29.56% | 24.07% | 23.29% | 29.86% | 26.93% |
| Normalized Basic EPS | 30.01% | 22.39% | 21.74% | 28.50% | 25.65% |
| EPS Diluted | 29.56% | 24.07% | 23.29% | 29.86% | 26.93% |
| Normalized Diluted EPS | 30.01% | 22.39% | 21.74% | 28.50% | 25.65% |
| Average Basic Shares Outstanding | 12.33% | 12.36% | 12.50% | 12.31% | 12.68% |
| Average Diluted Shares Outstanding | 12.33% | 12.36% | 12.50% | 12.31% | 12.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |